Viraday Tablets

Viraday Tablets Specification

Dosage Form
Solid (Tablet)

Packaging Type
Bottle

Salt Composition
Efavirenz 600mg, Emtricitabine 200mg, Tenofovir disoproxil fumarate 300mg

Pacakaging (Quantity Per Box)
30 Tablets per bottle

Indication
Treatment of HIV infection

Origin of Medicine
Cipla, India

Life Span
24 months

Brand Name
Viraday

Drug Type
Allopathic

Ingredients
Emtricitabine, Tenofovir, Efavirenz

Physical Form
Tablets

Function
Antiretroviral therapy

Recommended For
HIV-1 Infection

Dosage
As directed by physician

Dosage Guidelines
Take one tablet once daily, preferably at the same time each day

Suitable For
Adults

Quantity
30 tablets

Storage Instructions
Store in a cool, dry place

Cautions
Not for pediatric use. Use with caution in patients with renal or hepatic impairment.

Therapeutic Class
Antiretroviral combination

Intended Patient Population
Adult patients diagnosed with HIV-1 infection

Expiry Date
As mentioned on pack (usually shelf life 2 years from manufacture)

Shape
Capsule-shaped

Regulatory Approval
WHO Prequalified, USFDA approved

Color
Yellow

Side Effects
Dizziness, nausea, rash, fatigue, insomnia (consult physician for full list)

Route of Administration
Oral

Manufactured By
Cipla Ltd.

About Viraday Tablets

Redeem unparalleled health with grand protection through Viraday Tablets, a sublime antiviral solution by Cipla Ltd. This WHO prequalified medicine delivers instant savings on long-term therapy for adults battling HIV-1 infection. Each sizzling yellowish orange tablet blends Emtricitabine, Tenofovir, and Efavirenz for superior efficacy. Administered orally, Viraday ensures consistent antiretroviral therapy-simply take one tablet daily as directed by your physician. Suitable for global markets, its robust packaging retains potency for up to 24 months. Prescription required. Caution: Consult your doctor for potential side effects.

Additional Uses and Suitability of Viraday Tablets

Viraday Tablets are primarily designed for adults undergoing treatment for HIV-1 infection; however, their potent formulation is also researched for potential off-label use in specific clinical situations as advised by healthcare professionals. Due to their rigorous composition and regulatory approval, these tablets are wholly suitable for use in medicinal settings and are not intended for plant or non-human applications. Always consult a specialist for proper guidance on any alternative applications or suitability concerns.

Sample Policy, Export Markets, and Delivery of Viraday Tablets

Viraday Tablets are efficiently packaged in bottles containing 30 tablets each, ensuring secure logistics and product integrity during shipping. Samples may be available for qualified inquiries, adhering to strict pharmaceutical protocols. These tablets are delivered to international markets, addressing the needs of global healthcare providers. Clients can expect reliable tracking and handling through the supply chain, from packaging to doorstep delivery. Please contact your supplier or trader to inquire about sample availability and export logistics.

FAQ's of Viraday Tablets:

Q: How should Viraday Tablets be taken for optimal effectiveness?

A: Viraday Tablets should be taken orally, once daily, preferably at the same time each day, exactly as directed by your physician to ensure consistent antiretroviral coverage and effectiveness.

Q: What are the main ingredients in Viraday Tablets and their functions?

A: Each Viraday Tablet contains Emtricitabine, Tenofovir disoproxil fumarate, and Efavirenz, which work together to suppress the HIV-1 virus and slow disease progression as part of combination antiretroviral therapy.

Q: When is it appropriate to use Viraday Tablets?

A: Viraday Tablets are indicated for the treatment of HIV-1 infection in adults. Usage should only commence under medical supervision with a valid prescription.

Q: Where are Viraday Tablets manufactured and are they internationally recognized?

A: Viraday Tablets are manufactured by Cipla Ltd., India, and are internationally recognized, holding WHO prequalification for quality and efficacy.

Q: What should be considered regarding side effects and storage of Viraday Tablets?

A: Consult your physician regarding potential adverse effects before use. Store the tablets in a cool, dry place, out of reach of children, to maintain product quality and safety.